Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
4.785
+0.075 (1.59%)
May 3, 2024, 11:19 AM EDT - Market open

Novavax Revenue

In the year 2023, Novavax had annual revenue of $983.71M, a decrease of -50.36%. Revenue in the quarter ending December 31, 2023 was $291.34M, a -18.48% decrease year-over-year.

Revenue (ttm)
$983.71M
Revenue Growth
-50.36%
P/S Ratio
0.67
Revenue / Employee
$637,528
Employees
1,543
Market Cap
671.83M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023983.71M-998.17M-50.36%
Dec 31, 20221.98B835.58M72.89%
Dec 31, 20211.15B670.69M141.02%
Dec 31, 2020475.60M456.94M2,448.48%
Dec 31, 201918.66M-15.63M-45.57%
Dec 31, 201834.29M3.11M9.98%
Dec 31, 201731.18M15.82M103.06%
Dec 31, 201615.35M-20.90M-57.65%
Dec 31, 201536.25M5.59M18.24%
Dec 31, 201430.66M9.74M46.59%
Dec 31, 201320.92M-1.16M-5.26%
Dec 31, 201222.08M7.39M50.30%
Dec 31, 201114.69M14.35M4,182.22%
Dec 31, 2010343.00K18.00K5.54%
Dec 31, 2009325.00K-739.00K-69.45%
Dec 31, 20081.06M-449.00K-29.68%
Dec 31, 20071.51M-225.00K-12.95%
Dec 31, 20061.74M-3.61M-67.47%
Dec 31, 20055.34M-2.92M-35.31%
Dec 31, 20048.26M-3.53M-29.91%
Dec 31, 200311.79M-3.22M-21.46%
Dec 31, 200215.01M-9.06M-37.65%
Dec 31, 200124.07M21.59M872.36%
Dec 31, 20002.48M1.29M109.57%
Dec 31, 19991.18M500.00K73.42%
Dec 31, 1998681.00K161.00K30.96%
Dec 31, 1997520.00K464.00K828.57%
Dec 31, 199656.00K-212.00K-79.10%
Dec 31, 1995268.00K-416.88K-60.87%
Dec 31, 1994684.88K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.